Probiotics in the management of eczema

A Double-Blind, Randomised, Placebo controlled study to identify markers for the differential response of children with eczema following treatment with probiotics.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000615684

Enrollment

Registered

2005-10-07

Start date

2004-08-11

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Children aged 6 month to 12 years with eczema (Scorad of greater than 15) given lactobillus GG 3x10e8 to 1x10e9 cfu twice daily for 8 weeks observation.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

6 Months to 12 Years

Healthy volunteers

Inclusion criteria

Eczema - SCORAD of 15 or greaterGuardian's proficient in EnglishNot previously actively treated with probiotics for eczema. No current chronic illness other than asthma, allergic, rhinitis or food allergy.

Exclusion criteria

No exclusion criteria

Outcome results